JHVEPhoto Shares of healthcare solutions behemoth CVS Health Corporation (NYSE:CVS) are down some 25% since April 1, 2024, as an abysmal 1Q24 report and downward revised expectations for FY24 weigh. The company is experiencing a higher-than-expected medical benefit ratio in its Medicare Advantage plans, while it is ineligible for full level quality bonuses in FY24 due to fewer 4-star plans. With 87% of its Advantage members expected to return to 4+ star plans (setting up a stronger FY25) and a safe 4.4% div ...